FoundationOne CDx is Now FDA Approved as a Diagnostic Tool For ALK+ Non-Small Cell Lung Cancer
source: pixabay.com

FoundationOne CDx is Now FDA Approved as a Diagnostic Tool For ALK+ Non-Small Cell Lung Cancer

FoundationOne CDx is a comprehensive genomic profiling test that is tissue based. It is used to identify individuals diagnosed with ALK+ non-small-cell lung cancer (NSCLC) who will be eligible for…

Continue Reading FoundationOne CDx is Now FDA Approved as a Diagnostic Tool For ALK+ Non-Small Cell Lung Cancer

Study Shows How to Better Predict Pacemaker Needs in Myotonic Dystrophy Patients

A recent study has examined what risk factors exist for patients diagnosed with myotonic dystrophy, the most common of all muscular dystrophies. This is a progressive, hereditary condition. Regarding cardiac…

Continue Reading Study Shows How to Better Predict Pacemaker Needs in Myotonic Dystrophy Patients
Phase 3 Trial for Non-Germinal Center Diffuse Large B-Cell Lymphoma is Still Enrolling Patients
source: pixabay.com

Phase 3 Trial for Non-Germinal Center Diffuse Large B-Cell Lymphoma is Still Enrolling Patients

A Phase 3 clinical trial for Non-Germinal Center Diffuse Large B-Cell Lymphoma in patients where it was previously untreated have just announced they are still recruiting participants. The trial is…

Continue Reading Phase 3 Trial for Non-Germinal Center Diffuse Large B-Cell Lymphoma is Still Enrolling Patients
Experimental Treatment for Glycogen Storage Disease Type III Gets Orphan Designation in EU and US
source: pixabay.com

Experimental Treatment for Glycogen Storage Disease Type III Gets Orphan Designation in EU and US

According to a story from Market Watch, the biopharmaceutical company Ultragenyx Pharmaceutical, Inc. recently announced that it was given Orphan Drug designation from both the US Food and Drug Administration…

Continue Reading Experimental Treatment for Glycogen Storage Disease Type III Gets Orphan Designation in EU and US
New Study Has Demonstrated The Role of The Gut Microbiota in Neonatal Bacterial Meningitis
source: pixabay.com

New Study Has Demonstrated The Role of The Gut Microbiota in Neonatal Bacterial Meningitis

Bacterial meningitis is a severe condition that is linked to high mortality. Unfortunately, newborns are much more susceptible to bacterial meningitis. In fact, this infection occurs more than 30 times…

Continue Reading New Study Has Demonstrated The Role of The Gut Microbiota in Neonatal Bacterial Meningitis
Bardet-Biedl Syndrome: When the Cost of Testing Becomes a Barrier to Diagnosis
source: pixabay.com

Bardet-Biedl Syndrome: When the Cost of Testing Becomes a Barrier to Diagnosis

According to a story from MSN, mother Vanessa Ruiz is facing a terrifying choice: feed her family or pay for the genetic testing to confirm that her children Faith and…

Continue Reading Bardet-Biedl Syndrome: When the Cost of Testing Becomes a Barrier to Diagnosis
Experimental Drug Earns Orphan Drug Designation for Hypothalamic Obesity
source: pixabay.com

Experimental Drug Earns Orphan Drug Designation for Hypothalamic Obesity

According to a press release published on Globe Newswire, the biopharmaceutical company Saniona has announced recently that its investigational therapy Tesomet has recently earned Orphan Drug designation from the US…

Continue Reading Experimental Drug Earns Orphan Drug Designation for Hypothalamic Obesity
Is There a Right or Wrong in the Debate Between Patients and Manufacturers to Release Drugs Through Compassionate Use?
source: pixabay.com

Is There a Right or Wrong in the Debate Between Patients and Manufacturers to Release Drugs Through Compassionate Use?

  Following several Patient Worthy articles on the subject earlier this year, Fierce Biotech recently published news that Biogen is preparing to release the Phase III VALOR trial drug, tofersen,…

Continue Reading Is There a Right or Wrong in the Debate Between Patients and Manufacturers to Release Drugs Through Compassionate Use?
Study Finds Alpha-1 Antitrypsin Deficiency Could Benefit From Base Editing
source: pixabay.com

Study Finds Alpha-1 Antitrypsin Deficiency Could Benefit From Base Editing

Researchers from Boston University and Boston Medical Center have recently uncovered that base editing is able to correct the gene mutation which causes alpha-1 antitrypsin deficiency (A1AD). This condition impacts…

Continue Reading Study Finds Alpha-1 Antitrypsin Deficiency Could Benefit From Base Editing
Collaborative Study Provides Increased Understanding of Idiopathic Pulmonary Fibrosis
source: pixabay.com

Collaborative Study Provides Increased Understanding of Idiopathic Pulmonary Fibrosis

A study conducted by researchers at Nagoya University in Japan and researchers from Yale University in the United States was recently published in the European Respiratory Journal.  This study utilized single-cell…

Continue Reading Collaborative Study Provides Increased Understanding of Idiopathic Pulmonary Fibrosis
International Pemphigus & Pemphigoid Foundation Partners with the American Dental Association
source: pixabay.com

International Pemphigus & Pemphigoid Foundation Partners with the American Dental Association

The International Pemphigus & Pemphigoid Foundation (IPPF) has recently announced that is has partnered with the American Dental Association (ADA) for a continuing education course that will help dental professionals…

Continue Reading International Pemphigus & Pemphigoid Foundation Partners with the American Dental Association